Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,577 | 3,367 | 19,636 | 38,889 | 2,691 |
| Other current assets | 164 | 178 | 470 | 744 | 914 |
| TOTAL | $4,988 | $3,598 | $20,405 | $39,635 | $4,097 |
| Non-Current Assets | |||||
| PPE Net | 733 | 954 | 1,067 | 607 | 458 |
| TOTAL | $733 | $954 | $1,067 | $607 | $458 |
| Total Assets | $5,721 | $4,552 | $21,472 | $40,242 | $4,555 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,728 | 3,912 | 5,823 | 8,941 | 6,672 |
| Accrued Expenses | 1,874 | 5,037 | 4,239 | 1,764 | 1,859 |
| Other current liabilities | 2,358 | 2,453 | 2,622 | 5,761 | 5,691 |
| TOTAL | $6,960 | $11,403 | $12,683 | $16,465 | $14,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,925 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 13,422 | 11,205 | 9,190 | 0 | 44,207 |
| TOTAL | $18,347 | $11,205 | $9,190 | $N/A | $44,207 |
| Total Liabilities | $25,307 | $22,608 | $21,873 | $16,465 | $58,429 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,966 | 3,470 | 3,391 | 3,356 | N/A |
| Retained earnings | -144,182 | -133,397 | -110,939 | -82,948 | -52,735 |
| Other shareholders' equity | -632 | -431 | -292 | -625 | -1,523 |
| TOTAL | $-19,586 | $-18,056 | $-401 | $23,777 | $-53,874 |
| Total Liabilities And Equity | $5,721 | $4,552 | $21,472 | $40,242 | $4,555 |